ReP USP - Resultado da busca

Artigo de periodico
Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients (2022)
Jarduli, Luciana Ribeiro; Azevedo, Júlia Teixeira Cottas de; Clave, Emmanuel; Costa, Thalita Cristina de Mello; Arruda, Lucas Coelho Marliére; Fournier, Isabelle; Palma, Patricia Vianna Bonini; Lima, Keli Cristina de; Dias, Juliana Bernardes Elias; Stracieri, Ana Beatriz Pereira Lima; Pieroni, Fabiano; Cunha, Renato Luiz Guerino; Darrigo Júnior, Luiz Guilherme; Grecco, Carlos Eduardo Setanni; Covas, Dimas Tadeu; Pinto, Ana Cristina Silva; De Santis, Gil Cunha; Simões, Belinda Pinto; Rodrigues, Maria Carolina de Oliveira; Toubert, Antoine; Farias, Kelen Cristina Ribeiro Malmegrim de
Source: Clinical & Translational Immunology. Unidades: FMRP, FCFRP, FM
Subjects: CÉLULAS-TRONCO, HOMEOSTASE, REGENERAÇÃO (FENÔMENOS BIOLÓGICOS), ANEMIA FALCIFORME
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
JARDULI, Luciana Ribeiro et al. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Clinical & Translational Immunology, v. 11, n. 4, p. 1-16, 2022Tradução . . Disponível em: https://doi.org/10.1002/cti2.1389. Acesso em: 19 nov. 2024.
APA
Jarduli, L. R., Azevedo, J. T. C. de, Clave, E., Costa, T. C. de M., Arruda, L. C. M., Fournier, I., et al. (2022). Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients. Clinical & Translational Immunology, 11( 4), 1-16. doi:10.1002/cti2.1389
NLM
Jarduli LR, Azevedo JTC de, Clave E, Costa TC de M, Arruda LCM, Fournier I, Palma PVB, Lima KC de, Dias JBE, Stracieri ABPL, Pieroni F, Cunha RLG, Darrigo Júnior LG, Grecco CES, Covas DT, Pinto ACS, De Santis GC, Simões BP, Rodrigues MC de O, Toubert A, Farias KCRM de. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients [Internet]. Clinical & Translational Immunology. 2022 ; 11( 4): 1-16.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1002/cti2.1389
Vancouver
Jarduli LR, Azevedo JTC de, Clave E, Costa TC de M, Arruda LCM, Fournier I, Palma PVB, Lima KC de, Dias JBE, Stracieri ABPL, Pieroni F, Cunha RLG, Darrigo Júnior LG, Grecco CES, Covas DT, Pinto ACS, De Santis GC, Simões BP, Rodrigues MC de O, Toubert A, Farias KCRM de. Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients [Internet]. Clinical & Translational Immunology. 2022 ; 11( 4): 1-16.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1002/cti2.1389
Artigo de periodico
Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients (2021)
Lima-Júnior, João R.; Arruda, Lucas C. M.; Gonçalves, Maynara Santana; Dias, Juliana B. E.; Moraes, Daniela A.; Covas, Dimas Tadeu; Simões, Belinda Pinto; Oliveira, Maria Carolina; Malmegrim, Kelen Cristina Ribeiro
Source: Rheumatology. Unidades: FMRP, FCFRP
Subjects: DOENÇAS AUTOIMUNES, TRANSPLANTE AUTÓLOGO, CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, INTERLEUCINAS, SISTEMA IMUNE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA-JÚNIOR, João R. et al. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology, v. 60, n. 12, p. 5538–5548, 2021Tradução . . Disponível em: https://doi.org/10.1093/rheumatology/keab257. Acesso em: 19 nov. 2024.
APA
Lima-Júnior, J. R., Arruda, L. C. M., Gonçalves, M. S., Dias, J. B. E., Moraes, D. A., Covas, D. T., et al. (2021). Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients. Rheumatology, 60( 12), 5538–5548. doi:10.1093/rheumatology/keab257
NLM
Lima-Júnior JR, Arruda LCM, Gonçalves MS, Dias JBE, Moraes DA, Covas DT, Simões BP, Oliveira MC, Malmegrim KCR. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients [Internet]. Rheumatology. 2021 ; 60( 12): 5538–5548.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/rheumatology/keab257
Vancouver
Lima-Júnior JR, Arruda LCM, Gonçalves MS, Dias JBE, Moraes DA, Covas DT, Simões BP, Oliveira MC, Malmegrim KCR. Autologous haematopoietic stem cell transplantation restores the suppressive capacity of regulatory B cells in systemic sclerosis patients [Internet]. Rheumatology. 2021 ; 60( 12): 5538–5548.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1093/rheumatology/keab257
Artigo de periodico
New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis (2021)
Burt, Richard K.; Muraro, Paolo A.; Farge, Dominique; Oliveira, Maria Carolina; Snowden, John A.; Saccardi, Riccardo; Han, Xiaoqiang; Quigley, Kathleen; Bueno, Valquiria; Frasca, Daniela; Fedorenko, Denis; Burman, Joachim
Source: Bone Marrow Transplantation. Unidade: FMRP
Subjects: DOENÇAS AUTOIMUNES, DOENÇA ENXERTO-HOSPEDEIRO, CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, ESCLEROSE MÚLTIPLA, TRANSPLANTE AUTÓLOGO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURT, Richard K. et al. New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplantation, v. 56, n. 7, p. 1509-1517, 2021Tradução . . Disponível em: https://doi.org/10.1038/s41409-021-01277-y. Acesso em: 19 nov. 2024.
APA
Burt, R. K., Muraro, P. A., Farge, D., Oliveira, M. C., Snowden, J. A., Saccardi, R., et al. (2021). New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis. Bone Marrow Transplantation, 56( 7), 1509-1517. doi:10.1038/s41409-021-01277-y
NLM
Burt RK, Muraro PA, Farge D, Oliveira MC, Snowden JA, Saccardi R, Han X, Quigley K, Bueno V, Frasca D, Fedorenko D, Burman J. New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis [Internet]. Bone Marrow Transplantation. 2021 ; 56( 7): 1509-1517.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1038/s41409-021-01277-y
Vancouver
Burt RK, Muraro PA, Farge D, Oliveira MC, Snowden JA, Saccardi R, Han X, Quigley K, Bueno V, Frasca D, Fedorenko D, Burman J. New autoimmune diseases after autologous hematopoietic stem cell transplantation for multiple sclerosis [Internet]. Bone Marrow Transplantation. 2021 ; 56( 7): 1509-1517.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1038/s41409-021-01277-y
Artigo de periodico
Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy (2020)
Mastellos, Dimitrios C.; Silva, Bruno Garcia Peixoto Pires da; Fonseca, Benedito Antonio Lopes da; Fonseca, Natasha Peixoto; Martins, Maria Auxiliadora; Mastaglio, Sara; Ruggeri, Annalisa; Sironi, Marina; Radermacher, Peter; Chrysanthopoulou, Akrivi; Skendros, Panagiotis; Ritis, Konstantinos; Manfra, Ilenia; Iacobelli, Simona; Huber-Lang, Markus; Nilsson, Bo; Yancopoulou, Despina; Connolly, E. Sander; Garlanda, Cecilia; Ciceri, Fabio; Risitano, Antonio M.; Calado, Rodrigo Tocantins; Lambris, John D.
Source: Clinical Immunology. Unidade: FMRP
Subjects: COVID-19, TROMBOSE, FÁRMACOS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MASTELLOS, Dimitrios C. et al. Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy. Clinical Immunology, v. 220, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.clim.2020.108598. Acesso em: 19 nov. 2024.
APA
Mastellos, D. C., Silva, B. G. P. P. da, Fonseca, B. A. L. da, Fonseca, N. P., Martins, M. A., Mastaglio, S., et al. (2020). Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy. Clinical Immunology, 220. doi:10.1016/j.clim.2020.108598
NLM
Mastellos DC, Silva BGPP da, Fonseca BAL da, Fonseca NP, Martins MA, Mastaglio S, Ruggeri A, Sironi M, Radermacher P, Chrysanthopoulou A, Skendros P, Ritis K, Manfra I, Iacobelli S, Huber-Lang M, Nilsson B, Yancopoulou D, Connolly ES, Garlanda C, Ciceri F, Risitano AM, Calado RT, Lambris JD. Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy [Internet]. Clinical Immunology. 2020 ; 220[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.clim.2020.108598
Vancouver
Mastellos DC, Silva BGPP da, Fonseca BAL da, Fonseca NP, Martins MA, Mastaglio S, Ruggeri A, Sironi M, Radermacher P, Chrysanthopoulou A, Skendros P, Ritis K, Manfra I, Iacobelli S, Huber-Lang M, Nilsson B, Yancopoulou D, Connolly ES, Garlanda C, Ciceri F, Risitano AM, Calado RT, Lambris JD. Complement C3 vs C5 inhibition in severe COVID-19: early clinical findings reveal differential biological efficacy [Internet]. Clinical Immunology. 2020 ; 220[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.clim.2020.108598
Parte de monografia/livro
Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers (2020)
Farias, Kelen Cristina Ribeiro Malmegrim de ; Lima Júnior, João Rodrigues; Arruda, Lucas Coelho Marliére; Azevedo, Júlia Teixeira Cottas de; Oliveira, Gislane Lelis Vilela de; Rodrigues, Maria Carolina de Oliveira
Source: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Unidades: FCFRP, FMRP
Subjects: CÉLULAS-TRONCO, TRANSPLANTE DE ÓRGÃOS, DOENÇAS AUTOIMUNES, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FARIAS, Kelen Cristina Ribeiro Malmegrim de et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers. Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Tradução . Lausanne: Frontiers Media, 2020. . Disponível em: https://doi.org/10.3389/978-2-88963-472-9. Acesso em: 19 nov. 2024.
APA
Farias, K. C. R. M. de, Lima Júnior, J. R., Arruda, L. C. M., Azevedo, J. T. C. de, Oliveira, G. L. V. de, & Rodrigues, M. C. de O. (2020). Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers. In Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand?. Lausanne: Frontiers Media. doi:10.3389/978-2-88963-472-9
NLM
Farias KCRM de, Lima Júnior JR, Arruda LCM, Azevedo JTC de, Oliveira GLV de, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Vancouver
Farias KCRM de, Lima Júnior JR, Arruda LCM, Azevedo JTC de, Oliveira GLV de, Rodrigues MC de O. Autologous hematopoietic stem cell transplantation for autoimmune diseases: from mechanistic insights to biomarkers [Internet]. In: Immune profile after autologous hematopoietic stem cell transplantation for autoimmune diseases: where do we stand? Lausanne: Frontiers Media; 2020. [citado 2024 nov. 19 ] Available from: https://doi.org/10.3389/978-2-88963-472-9
Trabalho de evento-resumo periodico
Differential reconstitution of B-cell subsets in systemic sclerosis patients after autologous hematopoietic stem cell transplantation (2019)
Lima Júnior, João Rodrigues; Arruda, Lucas Coelho Marliére; Gonçalves, Maynara Santana; Azevedo, Júlia Teixeira Cottas de; Moraes, Daniela A.; Covas, Dimas Tadeu ; Oliveira, Maria Carolina ; Farias, Kelen Cristina Ribeiro Malmegrim de
Source: Annals of the Rheumatic Diseases. Conference titles: Annual European Congress of Rheumatology - EULAR. Unidades: FMRP, FCFRP
Subjects: CÉLULAS-TRONCO, TRANSPLANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA JÚNIOR, João Rodrigues et al. Differential reconstitution of B-cell subsets in systemic sclerosis patients after autologous hematopoietic stem cell transplantation. Annals of the Rheumatic Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1136/annrheumdis-2019-eular.2863. Acesso em: 19 nov. 2024. , 2019
APA
Lima Júnior, J. R., Arruda, L. C. M., Gonçalves, M. S., Azevedo, J. T. C. de, Moraes, D. A., Covas, D. T., et al. (2019). Differential reconstitution of B-cell subsets in systemic sclerosis patients after autologous hematopoietic stem cell transplantation. Annals of the Rheumatic Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1136/annrheumdis-2019-eular.2863
NLM
Lima Júnior JR, Arruda LCM, Gonçalves MS, Azevedo JTC de, Moraes DA, Covas DT, Oliveira MC, Farias KCRM de. Differential reconstitution of B-cell subsets in systemic sclerosis patients after autologous hematopoietic stem cell transplantation [Internet]. Annals of the Rheumatic Diseases. 2019 ; 78 1065.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1136/annrheumdis-2019-eular.2863
Vancouver
Lima Júnior JR, Arruda LCM, Gonçalves MS, Azevedo JTC de, Moraes DA, Covas DT, Oliveira MC, Farias KCRM de. Differential reconstitution of B-cell subsets in systemic sclerosis patients after autologous hematopoietic stem cell transplantation [Internet]. Annals of the Rheumatic Diseases. 2019 ; 78 1065.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1136/annrheumdis-2019-eular.2863
Artigo de periodico
Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial (2019)
Burt, Richard K. ; Balabanov, Roumen; Burman, Joachim ; Sharrack, Basil; Snowden, John A.; Oliveira, Maria Carolina ; Fagius, Jan; Rose, John; Nelson, Flavia; Barreira, Amilton Antunes; Carlson, Kristina; Han, Xiaoqiang; Moraes, Daniela; Morgan, Amy; Quigley, Kathleen; Yaung, Kimberly; Buckley, Regan; Alldredge, Carri; Clendenan, Allison; Calvario, Michelle A.; Henry, Jacquelyn; Jovanovic, Borko; Helenowski, Irene B.
Source: Jama. Unidade: FMRP
Subjects: CÉLULAS-TRONCO, ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURT, Richard K. et al. Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial. Jama, v. 321, n. 2, p. 165-174, 2019Tradução . . Disponível em: https://doi.org/10.1001/jama.2018.18743. Acesso em: 19 nov. 2024.
APA
Burt, R. K., Balabanov, R., Burman, J., Sharrack, B., Snowden, J. A., Oliveira, M. C., et al. (2019). Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial. Jama, 321( 2), 165-174. doi:10.1001/jama.2018.18743
NLM
Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA, Carlson K, Han X, Moraes D, Morgan A, Quigley K, Yaung K, Buckley R, Alldredge C, Clendenan A, Calvario MA, Henry J, Jovanovic B, Helenowski IB. Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial [Internet]. Jama. 2019 ; 321( 2): 165-174.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1001/jama.2018.18743
Vancouver
Burt RK, Balabanov R, Burman J, Sharrack B, Snowden JA, Oliveira MC, Fagius J, Rose J, Nelson F, Barreira AA, Carlson K, Han X, Moraes D, Morgan A, Quigley K, Yaung K, Buckley R, Alldredge C, Clendenan A, Calvario MA, Henry J, Jovanovic B, Helenowski IB. Effect of nonmyeloablative hematopoietic stem cell transplantation vs continued disease-modifying therapy on disease progression in patients with relapsing-remitting multiple sclerosis: a randomized clinical trial [Internet]. Jama. 2019 ; 321( 2): 165-174.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1001/jama.2018.18743
Trabalho de evento-anais periodico
Guide and position of the International Society of nutrigenetics/nutrigenomics on personalised nutrition: part 1 - fields of precision nutrition (2016)
Ferguson, Lynnette R.; De Caterina, Raffaele; Görman, Ulf; Allayee, Hooman; Kohlmeier, Martin; Prasad, Chandan; Choi, Myung Sook; Curi, Rui; Luis, Daniel Antonio de; Gil, Angel; Kang, Jing X.; Martin, Ron L.; Milagro, Fermin I.; Nicoletti, Carolina Ferreira; Nonino, Carla Barbosa
Source: Journal of Nutregenetics and Nutregenomics. Conference titles: Congress of the International Society of Nutrigenetics/Nutrigenomics. Unidades: ICB, FMRP
Subjects: NUTRIGENÔMICA, NUTRIÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERGUSON, Lynnette R. et al. Guide and position of the International Society of nutrigenetics/nutrigenomics on personalised nutrition: part 1 - fields of precision nutrition. Journal of Nutregenetics and Nutregenomics. Basel: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1159/000445350. Acesso em: 19 nov. 2024. , 2016
APA
Ferguson, L. R., De Caterina, R., Görman, U., Allayee, H., Kohlmeier, M., Prasad, C., et al. (2016). Guide and position of the International Society of nutrigenetics/nutrigenomics on personalised nutrition: part 1 - fields of precision nutrition. Journal of Nutregenetics and Nutregenomics. Basel: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1159/000445350
NLM
Ferguson LR, De Caterina R, Görman U, Allayee H, Kohlmeier M, Prasad C, Choi MS, Curi R, Luis DA de, Gil A, Kang JX, Martin RL, Milagro FI, Nicoletti CF, Nonino CB. Guide and position of the International Society of nutrigenetics/nutrigenomics on personalised nutrition: part 1 - fields of precision nutrition [Internet]. Journal of Nutregenetics and Nutregenomics. 2016 ; 9 12-27.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1159/000445350
Vancouver
Ferguson LR, De Caterina R, Görman U, Allayee H, Kohlmeier M, Prasad C, Choi MS, Curi R, Luis DA de, Gil A, Kang JX, Martin RL, Milagro FI, Nicoletti CF, Nonino CB. Guide and position of the International Society of nutrigenetics/nutrigenomics on personalised nutrition: part 1 - fields of precision nutrition [Internet]. Journal of Nutregenetics and Nutregenomics. 2016 ; 9 12-27.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1159/000445350
Artigo de periodico
Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics (2016)
Lonn, Eva; Bosch, Jackie; Pogue, Janice; Avezum, Alvaro; Chazova, Irina; Dans, Antonio; Diaz, Rafael; Fodor, George J.; Held, Claes; Jansky, Petr; Keltai, Matyas; Keltai, Katalin; kunti, Kamlesh; Kim, Jae-Hyung; Leiter, Lawrence; Lewis, Basil; Liu, Lisheng; Lopez-Jaramillo, Patricio; Pais, Prem; Parkhomenko, Alexandr; Peters, Ron J. G; Piegas, Leopoldo S; Reid, Christopher M; Sliwa, Karen; Toff, William D; Varigos, John; Xavier, Denis; Yusoff, Khalid; Zhu, Jun; Dagenais, Gilles; Yusuf, Salim; Marin Neto, José Antonio
Source: Canadian Journal of Cardiology. Unidade: FMRP
Subjects: RECEPTORES DE ANGIOTENSINA, PRESSÃO SANGUÍNEA, DOENÇAS CARDIOVASCULARES, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LONN, Eva et al. Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics. Canadian Journal of Cardiology, v. 32, n. 3, p. 311-318, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.cjca.2015.07.001. Acesso em: 19 nov. 2024.
APA
Lonn, E., Bosch, J., Pogue, J., Avezum, A., Chazova, I., Dans, A., et al. (2016). Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics. Canadian Journal of Cardiology, 32( 3), 311-318. doi:10.1016/j.cjca.2015.07.001
NLM
Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A, Diaz R, Fodor GJ, Held C, Jansky P, Keltai M, Keltai K, kunti K, Kim J-H, Leiter L, Lewis B, Liu L, Lopez-Jaramillo P, Pais P, Parkhomenko A, Peters RJG, Piegas LS, Reid CM, Sliwa K, Toff WD, Varigos J, Xavier D, Yusoff K, Zhu J, Dagenais G, Yusuf S, Marin Neto JA. Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics [Internet]. Canadian Journal of Cardiology. 2016 ; 32( 3): 311-318.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.cjca.2015.07.001
Vancouver
Lonn E, Bosch J, Pogue J, Avezum A, Chazova I, Dans A, Diaz R, Fodor GJ, Held C, Jansky P, Keltai M, Keltai K, kunti K, Kim J-H, Leiter L, Lewis B, Liu L, Lopez-Jaramillo P, Pais P, Parkhomenko A, Peters RJG, Piegas LS, Reid CM, Sliwa K, Toff WD, Varigos J, Xavier D, Yusoff K, Zhu J, Dagenais G, Yusuf S, Marin Neto JA. Novel approaches in primary cardiovascular disease prevention: the HOPE-3 trial rationale, design, and participants' baseline characteristics [Internet]. Canadian Journal of Cardiology. 2016 ; 32( 3): 311-318.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.cjca.2015.07.001
Artigo de periodico
Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis (2015)
Burt, Richard K.; Balabanov, Roumen; Han, Xiaoqiang; Sharrack, Basil; Morgan, Amy; Quigley, Kathleen; Yaung, Kim; Helenowski, Irene B.; Javanovic, Borko; Spahovic, Dzemila; Arnautovic, Indira; Lee, Daniel C.; Benefield, Brandon C.; Futterer, Stephen; Oliveira, Maria Carolina; Burman, Joachim
Source: JAMA : The Journal of the American Medical Association. Unidade: FMRP
Subjects: HEMATOPOESE, CÉLULAS-TRONCO, TRANSPLANTES, ESCLEROSE MÚLTIPLA, TERAPÊUTICA MÉDICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BURT, Richard K. et al. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis. JAMA : The Journal of the American Medical Association, v. 313, n. 3, p. 275-284, 2015Tradução . . Disponível em: https://doi.org/10.1001/jama.2014.17986. Acesso em: 19 nov. 2024.
APA
Burt, R. K., Balabanov, R., Han, X., Sharrack, B., Morgan, A., Quigley, K., et al. (2015). Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis. JAMA : The Journal of the American Medical Association, 313( 3), 275-284. doi:10.1001/jama.2014.17986
NLM
Burt RK, Balabanov R, Han X, Sharrack B, Morgan A, Quigley K, Yaung K, Helenowski IB, Javanovic B, Spahovic D, Arnautovic I, Lee DC, Benefield BC, Futterer S, Oliveira MC, Burman J. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis [Internet]. JAMA : The Journal of the American Medical Association. 2015 ; 313( 3): 275-284.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1001/jama.2014.17986
Vancouver
Burt RK, Balabanov R, Han X, Sharrack B, Morgan A, Quigley K, Yaung K, Helenowski IB, Javanovic B, Spahovic D, Arnautovic I, Lee DC, Benefield BC, Futterer S, Oliveira MC, Burman J. Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis [Internet]. JAMA : The Journal of the American Medical Association. 2015 ; 313( 3): 275-284.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1001/jama.2014.17986

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation

Countries of institutions of collaboration